000 01313 a2200397 4500
005 20250517200621.0
264 0 _c20181029
008 201810s 0 0 eng d
022 _a1529-8019
024 7 _a10.1111/dth.12591
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNasr, Mohamad M
245 0 0 _aBacillus Calmette-Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus.
_h[electronic resource]
260 _bDermatologic therapy
_cMay 2018
300 _ae12591 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBCG Vaccine
_xadverse effects
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLichen Planus
_xdrug therapy
650 0 4 _aLichen Planus, Oral
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNucleic Acids
_xadverse effects
650 0 4 _aPolysaccharides, Bacterial
_xadverse effects
650 0 4 _aYoung Adult
700 1 _aEbrahim, Howyda M
700 1 _aKhattab, Fathia M
700 1 _aMarei, Ayman M
773 0 _tDermatologic therapy
_gvol. 31
_gno. 3
_gp. e12591
856 4 0 _uhttps://doi.org/10.1111/dth.12591
_zAvailable from publisher's website
999 _c28048866
_d28048866